Basecamp Research completes $60 million Series B
Singular led the biological AI company’s October 2024 financing.
Basecamp Research announced a $60 million Series B led by Singular on October 9, 2024. Participants included S32, Redalpine, André Hoffmann, Feike Sijbesma and Paul Polman, alongside returning investors True Ventures and Hummingbird Ventures.
The company will use the financing to expand biological data collection, computing and AI models for therapeutic research. The announcement also introduced a collaboration with David Liu’s laboratory on genetic medicines.
Use of funds
Expand data collection, biological AI and computing